Chronic Obstructive Pulmonary Disorder (COPD) News and Research RSS Feed - Chronic Obstructive Pulmonary Disorder (COPD) News and Research
The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

The most common symptoms of COPD are breathlessness (or a "need for air"), abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough. Daily activities, such as walking up a short flight of stairs or carrying a suitcase, can become very difficult as the condition gradually worsens. There are significant unmet needs in the treatment of COPD including limited therapeutic options to improve lung function and control exacerbations.
Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA). [More]
UK’s health performance: an interview with Prof. Murray, University of Washington

UK’s health performance: an interview with Prof. Murray, University of Washington

Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind. [More]
COPD phase III study by Almirall and Forest Laboratories announces positive results

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA). [More]
£1.2 billion over five years to be saved with Telehealth roll out in UK

£1.2 billion over five years to be saved with Telehealth roll out in UK

Telehealth or telecare in health may soon allow people with long term conditions like heart disease, diabetes and chronic obstructive pulmonary disorder (COPD) to manage their illness largely from home feel authorities. [More]
Volunteers needed in worldwide study to help people breathe easier

Volunteers needed in worldwide study to help people breathe easier

Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment. [More]

New paper provides unique review on respiratory disorders in the Middle East

Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society of Respirology, provides pulmonologists and patients with the first comprehensive review of respiratory illnesses specific to the Persian Gulf region, and the challenges in treating them. [More]

Study finds inhaled corticosteroids increase type 2 diabetes risk

Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics. [More]
Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data, Inc. today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company's new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering . [More]
Clinical Data fiscal 2010 gross revenue increases 35% to $15.2 million

Clinical Data fiscal 2010 gross revenue increases 35% to $15.2 million

Clinical Data, Inc. today announced operational and financial results for the fourth fiscal quarter and fiscal year ended March 31, 2010, noting the Company's continued achievement of major clinical and business milestones. [More]

Wireless monitoring system for people with debilitating conditions

A wireless monitoring system for people with debilitating conditions such as Parkinson's disease or chronic obstructive pulmonary disorder could allow healthcare workers to assess a patient's health and the development of their disease without hindering their movements. Details of the system are reported in the International Journal of Biomedical Engineering and Technology. [More]

Self-treatment lowers overall health care costs for chronic obstructive pulmonary disorder sufferers

Individuals suffering from chronic obstructive pulmonary disorder (COPD) can experience significant savings in healthcare costs by employing a self-treatment program with the judicious use of medications, according to the results of a new study. The self-treatment program achieves these savings by reducing the duration of flare-ups. [More]
Body's defenses may worsen chronic obstructive pulmonary disorder

Body's defenses may worsen chronic obstructive pulmonary disorder

Although the immune system is designed to protect the body from harm, it may actually worsen one of the most difficult-to-treat respiratory diseases: chronic obstructive pulmonary disorder (COPD), according to new University of Cincinnati (UC) research. [More]
Patients to benefit from multi-million pound research funding

Patients to benefit from multi-million pound research funding

NHS patients in North West London will benefit from a multi-million pound research project leading to the rapid introduction of new, effective treatments for a wide range of medical conditions. [More]
Researchers launch lung cancer screening trial

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease. [More]
Self-management education for patients with chronic obstructive pulmonary disease

Self-management education for patients with chronic obstructive pulmonary disease

Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies. [More]

Impact of indoor air quality on COPD patients

Poor indoor air quality can significantly worsen health problems in people with chronic obstructive pulmonary disorder (COPD), according to researchers in Scotland. High concentrations of fine particulate pollution - the type of pollution associated with secondhand smoke and, in developing countries, indoor cooking and heating fires - were strongly linked to poorer health status. [More]
Hospital admission rates linked to social deprivation, not quality of GP care

Hospital admission rates linked to social deprivation, not quality of GP care

Researchers in London have identified a link between increased hospital admission rates for chronic diseases and high levels of material deprivation in the capital. [More]

Researchers identify mechanism which increases lung inflammation, making Chronic Obstructive Pulmonary Disorder (COPD) more severe

An international team of researchers has identified a mechanism which increases lung inflammation, making Chronic Obstructive Pulmonary Disorder (COPD) more severe, and potentially points towards new treatments. [More]